Difficulty: Medium
Average Score: 94%
Practice
A 36-year-old woman recently treated for leukemia is admitted to hospital with malaise, chills and high fever. Gram stain of blood reveals the presence of gram-negative bacilli. The initial diagnosis is bacteremia and parenteral antibiotics are indicated. The records of the patient reveal that she had a severe urticarial rash, hypotension, and respiratory difficulty following oral penicillin V about 6 months ago. The most appropriate drug regimen for empiric treatment is
Correct answer
B
Rationale
In this scenario, the most appropriate drug regimen for empiric treatment is option B) Aztreonam. Aztreonam is a monobactam antibiotic that is effective against gram-negative bacteria and is a suitable choice for patients with a history of severe allergic reactions to penicillin.
Option A) Ampicillin plus sulbactam contains penicillin, which poses a risk for cross-reactivity in patients with a history of severe penicillin allergy. Option C) Cefazolin is a first-generation cephalosporin, which also carries a risk of cross-reactivity with penicillin in patients with a history of severe penicillin allergy. Option D) Imipenem plus cilastatin is a carbapenem antibiotic that may also lead to cross-reactivity in patients with a history of severe penicillin allergy.
In an educational context, it is crucial for healthcare providers to consider a patient's allergy history when selecting appropriate antibiotic therapy to prevent adverse reactions. Understanding the pharmacology and potential cross-reactivities of antibiotics in patients with known allergies is essential for safe and effective treatment. This case highlights the importance of drug selection based on individual patient characteristics to optimize therapeutic outcomes and minimize risks.
Option A) Ampicillin plus sulbactam contains penicillin, which poses a risk for cross-reactivity in patients with a history of severe penicillin allergy. Option C) Cefazolin is a first-generation cephalosporin, which also carries a risk of cross-reactivity with penicillin in patients with a history of severe penicillin allergy. Option D) Imipenem plus cilastatin is a carbapenem antibiotic that may also lead to cross-reactivity in patients with a history of severe penicillin allergy.
In an educational context, it is crucial for healthcare providers to consider a patient's allergy history when selecting appropriate antibiotic therapy to prevent adverse reactions. Understanding the pharmacology and potential cross-reactivities of antibiotics in patients with known allergies is essential for safe and effective treatment. This case highlights the importance of drug selection based on individual patient characteristics to optimize therapeutic outcomes and minimize risks.